Market positioning Quorum Consulting operates at the intersection of biotechnology research and payer strategy, offering services in economic, reimbursement, and financial issues to help medical innovators monetize new technologies. This creates a sales opportunity to position as a specialized partner for early-stage biotech, medical device, and diagnostic companies seeking market access and pricing strategies.

Acquisition context Recent acquisition by Navigant Consulting suggests broader access to a larger client base, enhanced credibility, and potential cross-sell opportunities across management consulting, healthcare analytics, and policy advisory services for biopharma and medtech clients.

Revenue bands With reported revenue in the $1M–$10M range and a lean team, there is potential to scale services through strategic partnerships, white-label offerings, or expanded multi-project engagements with growing biotech startups and mid-size firms seeking expert market access solutions.

Technology leverage Existing tech stack includes analytics and web tools (Google Analytics, New Relic) and form/interaction tools (Gravity Forms, Select2), indicating opportunities to offer digital marketing optimization, pricing intelligence dashboards, and client onboarding enhancements to improve engagement and value delivery.

Target clients Client profile spans pharmaceutical, biotechnology, medical device, and molecular diagnostics companies. Sales efforts should focus on firms needing reimbursement strategy, patient access programs, and pricing strategies to accelerate product adoption and payer reimbursement success.